A minority of individuals experiencing traumatic events develop anxiety disorders. The reason for the lack of correspondence between the prevalence of exposure to psychological trauma and the development of anxiety is unknown. Extracellular proteolysis contributes to fear-associated responses by facilitating neuronal plasticity at the neuron-matrix interface 1-4 . Here we show in mice that the serine protease neuropsin is critical for stress-related plasticity in the amygdala by regulating the dynamics of the EphB2-NMDA-receptor interaction, the expression of Fkbp5 and anxiety-like behaviour. Stress results in neuropsin-dependent cleavage of EphB2 in the amygdala causing dissociation of EphB2 from the NR1 subunit of the NMDA receptor and promoting membrane turnover of EphB2 receptors. Dynamic EphB2-NR1 interaction enhances NMDA receptor current, induces Fkbp5 gene expression and enhances behavioural signatures of anxiety. On stress, neuropsin-deficient mice do not show EphB2 cleavage and its dissociation from NR1 resulting in a static EphB2-NR1 interaction, attenuated induction of the Fkbp5 gene and low anxiety. The behavioural response to stress can be restored by intraamygdala injection of neuropsin into neuropsin-deficient mice and disrupted by the injection of either anti-EphB2 antibodies or silencing the Fkbp5 gene in the amygdala of wild-type mice. Our findings establish a novel neuronal pathway linking stress-induced proteolysis of EphB2 in the amygdala to anxiety.
A minority of individuals experiencing traumatic events develop anxiety disorders. The reason for the lack of correspondence between the prevalence of exposure to psychological trauma and the development of anxiety is unknown. Extracellular proteolysis contributes to fear-associated responses by facilitating neuronal plasticity at the neuron-matrix interface [1] [2] [3] [4] . Here we show in mice that the serine protease neuropsin is critical for stress-related plasticity in the amygdala by regulating the dynamics of the EphB2-NMDA-receptor interaction, the expression of Fkbp5 and anxiety-like behaviour. Stress results in neuropsin-dependent cleavage of EphB2 in the amygdala causing dissociation of EphB2 from the NR1 subunit of the NMDA receptor and promoting membrane turnover of EphB2 receptors. Dynamic EphB2-NR1 interaction enhances NMDA receptor current, induces Fkbp5 gene expression and enhances behavioural signatures of anxiety. On stress, neuropsin-deficient mice do not show EphB2 cleavage and its dissociation from NR1 resulting in a static EphB2-NR1 interaction, attenuated induction of the Fkbp5 gene and low anxiety. The behavioural response to stress can be restored by intraamygdala injection of neuropsin into neuropsin-deficient mice and disrupted by the injection of either anti-EphB2 antibodies or silencing the Fkbp5 gene in the amygdala of wild-type mice. Our findings establish a novel neuronal pathway linking stress-induced proteolysis of EphB2 in the amygdala to anxiety.
Fear helps organisms recognize, memorize and predict danger, thereby promoting their survival. However, severe stress can trigger maladaptive forms of neuronal remodelling leading to generalization of fear and high anxiety 5 .
Traumatic events are memorized as a result of the capacity of synaptic connections and the surrounding matrix to undergo experiencedependent functional or morphological changes 1, 6 . Extracellular proteases are strategically poised to remodel the neuron-extracellular-matrix interface and facilitate fear and anxiety [2] [3] [4] . Eph-receptor tyrosine kinases constitute an important group of molecules subject to modulation by extracellular proteases 7 . Although Ephs promote neuronal plasticity 8, 9 , their involvement in behavioural responses to environmental stimuli is not clear.
Neuropsin is a serine protease uniquely positioned to facilitate stress-induced plasticity due to its high expression in the amygdala and hippocampus 10 . To investigate if neuropsin and Ephs co-localize we performed immunohistochemistry. Consistent with previous reports 10, 11 we found robust expression of both neuropsin and EphB2 in the amygdala ( Fig. 1 and Supplementary Fig. 1 ) and the hippocampus (not shown). Double immunohistochemistry revealed high levels of neuropsin co-localizing with EphB2-rich clusters on amygdala neurons (Fig. 1a) .
To assess whether Ephs are modulated by neuropsin we treated SH-SY5Y cells with neuropsin and measured the levels of Eph receptors by western blotting. We found that neuropsin (but not other proteases; Supplementary Fig. 2 ) cleaved EphB2 (decrease by 41%, P , 0.001), whereas the levels of other Ephs or their ligand, ephrinB2, remained unchanged ( Fig. 2a, b and Supplementary Fig. 3a ). When we expressed either GFP-tagged EphB2, GFP-tagged EphA4 or unlinked GFP in SH-SY5Y cells ( Supplementary Figs 4, 5 ) and treated them with neuropsin we saw a similar decrease in the EphB2-associated signal (Supplementary Fig. 5 ; P , 0.05).
When we used the above protocol to examine the composition of the SH-SY5Y or HEK293 cell culture medium after the application of neuropsin, we found a new ,70 kDa extracellular fragment of EphB2 released into the media (Fig. 2c Fig. 6a, b ). Next, we subjected wild-type and neuropsin 2/2 mice to restraint stress to activate the basolateral complex of the amygdala 12 . Neuropsin levels increased by 50% after stress and gradually normalized during recovery in this brain region ( Fig. 1c, d ; P , 0.05). Western blotting revealed a twofold increase in membrane-associated amygdala EphB2 levels after 15 min of restraint stress in neuropsin 2/2 mice (Fig. 2d , e and Supplementary Fig. 7 ; P , 0.05) indicative of new EphB2 receptors being incorporated into the membrane. This increase was not observed in wild-type mice, consistent with neuropsinmediated EphB2 cleavage during stress. Cleavage of EphB2 in the amygdala of wild-type mice was followed by a twofold increase in the expression of the Ephb2 gene ( Fig. 2f ; P , 0.001). The cleavage was substrate-specific because stress did not alter the levels of either ephrinB2 ( Supplementary Fig. 9a ) or a presynaptic neuropsin substrate, NCAM-L1 (also known as L1cam) 13 ( Supplementary Fig. 3b , c).
To determine the structural basis of neuropsin-specific EphB2 cleavage we analysed the fibronectin type III domain of EphB2 ( Supplementary Fig. 8 ) looking for similarities with the previously published neuropsin cleavage sequences 14 . We found a critical amino acid pair, Gly-Arg, at position 517 of EphB2 but not EphB1, EphB6 or EphA4. Consistent with our experimental findings cleavage of EphB2 at this site would result in the release of a ,70 kDa extracellular fragment.
The EphB2 receptors cluster and associate with NMDA receptors at excitatory synapses [15] [16] [17] . Indeed, co-immunoprecipitation revealed NR1 bound to EphB2 in the amygdala (Fig. 3a ). Restraint stress reduced the amount of EphB2 associated with NR1 at 15 min by 42% ( Fig. 3a, b ; P , 0.05) whereas NR1 levels were not altered ( Supplementary Fig. 9b-e ). Stress-induced decrease in the EphB2-NR1 association was not observed in neuropsin 2/2 mice but restored by intra-amygdala administration of neuropsin into these animals ( Fig. 3a, b ), consistent with neuropsin cleaving the extracellular portion of EphB2 during stress and triggering its dissociation from NR1. These results, together with stress-induced EphB2 membrane trafficking ( Fig. 2d, e ), indicate that neuropsin increases the dynamics of the EphB2-NR1 interaction after stress.
Regulating the EphB2-NMDA-receptor interaction results in modulation of the expression of NMDA-receptor-dependent genes facilitating synaptic plasticity 17 . To examine if neuropsin-mediated regulation of the EphB2-NR1 assembly affects gene expression in the amygdala we used microarrays in neuropsin 2/2 and wild-type mice. We found 19 differentially expressed transcripts with a marked upregulation of the Fkbp5 gene ( Fig. 3c, d and Supplementary Figs 10, 11; P , 0.0005). This gene encodes the Fkbp51 protein, which regulates glucocorticoid receptor sensitivity. Fkbp5 has been implicated in the development of anxiety, depression and post-traumatic stress disorder (PTSD) [18] [19] [20] . Quantitative polymerase chain reaction with reverse transcription (RT-qPCR) confirmed an increase in Fkbp5 gene expression in the amygdalae of stress-naive neuropsin 2/2 animals ( Fig. 3e ; P , 0.05).
The extent of upregulation of Fkbp5 messenger RNA shortly after trauma correlates with the development of PTSD 21 . If neuropsin regulates Fkbp5 gene expression then the magnitude of its stress-related regulation should be altered in neuropsin-deficient mice. When we analysed stress-induced Fkbp5 gene expression we found a 21-fold upregulation in wild-type amygdalae ( Fig. 3e ; P , 0.001) but an attenuated upregulation in neuropsin 2/2 mice. The increase in Fkbp5 gene expression was accompanied by a twofold upregulation of Fkbp51 protein levels in wild-type mice but not neuropsin 2/2 mice ( Fig. 3f , g; P , 0.05). These results indicate that neuropsin is a key regulator of the Fkbp5 gene and protein expression.
Neuropsin is an extracellular protease and thus unlikely to alter the expression of the Fkbp5 gene directly. Although the Fkbp5 gene can be regulated by glucocorticoids ( Supplementary Fig. 12 ), the above differences in Fkbp5 expression after stress cannot be attributed to corticosterone levels ( Supplementary Fig. 13 ). Interference with EphB2 signalling has recently been linked to the regulation of the Fkbp5 gene 22 . Indeed, when we mimicked stress in vitro by adding corticosterone into neuronal amygdala cultures, neuropsin-mediated upregulation of Fkbp5 was hindered by anti-EphB2 antibody ( Fig. 3h ; P , 0.001) and imitated by NMDA receptor stimulation ( Fig. 3i ; P , 0.05).
To address the effect of neuropsin on NMDA receptors directly we measured the evoked NMDA/AMPA current ratio in principal neurons of the basal amygdala in wild-type and neuropsin 2/2 mice. We found that, unlike in the hippocampus 13 , the NMDA current was markedly reduced by the deletion of the neuropsin gene, resulting in a ,50% drop in the NMDA/AMPA ratio ( Fig. 4a -c; P , 0.01).
We next asked if the neuropsin pathway affects neuronal plasticity in the amygdala. We induced early (E-LTP) or sustained (L-LTP) longterm potentiation in the amygdala lateral-basal pathway of wild-type and neuropsin 2/2 mice. Whereas basal synaptic responses were not altered ( Supplementary Fig. 14a ), E-LTP was impaired in neuropsin 2/2 mice ( Fig. 4d-f and Supplementary Fig. 14b , c; P , 0.001 versus wildtype at 20 min post-tetanus). These changes temporally correlated with neuropsin-mediated cleavage of EphB2, its dynamic interaction with NR1 and with the involvement of NMDA receptors in E-LTP in the lateral-basal pathway ( Supplementary Fig. 15 ). Supplementary Fig. 3a ). c, Exposure of EphB2-GFPtransfected SH-SY5Y or HEK293 cells to neuropsin (15 or 45 min) resulted in the appearance of a ,70 kDa amino-terminal EphB2 fragment in the medium ( Supplementary Fig. 6 ). WB, western blot. d, e, A twofold increase in membrane-associated EphB2 in neuropsin 2/2 (F (3, 12) 5 6.4; P , 0.05 versus non-stressed) but not wild-type mice was observed after stress (P , 0.05 versus stressed neuropsin 2/2 mice). f, RT-qPCR revealed a twofold upregulation of Ephb2 gene expression after 6 h stress (F (3, 23) 5 13.48; P , 0.001), not observed in neuropsin-deficient animals (P , 0.001 versus stressed wild-type mice). EphB2-S and EphB2-L describe short and long splice variants, respectively. NP, neuropsin. Digits inside columns indicate n. *P , 0.05, **P , 0.01, ***P , 0.001. Results are shown as mean 6 s.e.m. Control Stress   Trf  Ide  Myo7a  Tmem159  Hbb-b1  2310044H10Rik  Josd2  Fkbp5  EG664834  ENSMUSG00000073868  LOC236604  4933439C20Rik  D030013I16Rik  ColGa1  Tmem181  Ncam2 P , 0.05). c, Microarray analysis of wild-type and neuropsin 2/2 amygdalae revealed differential expression of Fkbp5 (heatmap in c, Supplementary Fig. 10 ). d, e, Exon-specific Fkbp5 probes showed an upregulation of the whole transcript (d) confirmed by RT-qPCR (e; F (3, 12) 5 72.15; P , 0.001).
LETTER RESEARCH
RT-qPCR revealed attenuated stress-induced upregulation of Fkbp5 in neuropsin 2/2 mice (e; P , 0.01 for wild-type after stress versus neuropsin 2/2 after stress) rescued by intra-amygdala neuropsin injections (F (3, 14) 5 9.2; P , 0.01). f, g, Fkbp51 protein levels were upregulated in wild-type mice (F (3, 14) 
RESEARCH LETTER
To examine if the neuropsin pathway alters behavioural signatures of stress we subjected wild-type and neuropsin 2/2 mice to acute or chronic stress and measured anxiety in the elevated-plus maze ( Fig. 4g-i ). We found that stress caused a decrease in the number of entries of wild-type mice into open arms, indicative of high anxiety levels 2, 3 . In contrast, after stress, neuropsin 2/2 mice did not develop anxiety ( Fig. 4g ; P , 0.05). Closed-arm entries, the total number of entries (Fig. 4h, i and Supplementary Fig. 16a, b) as well as general locomotor activity measures ( Supplementary Fig. 17d) were similar between the genotypes as previously reported 23 . Furthermore, neuropsin 2/2 mice demonstrated an anxiolytic phenotype in the open field test, confirming a general role of neuropsin in regulating anxiety ( Supplementary Fig. 17a-c) . Although this effect is consistent with functional deficits in NMDA receptor function (Fig. 4a-c ) and E-LTP ( Fig. 4d-f ) observed in neuropsin 2/2 mice, it cannot be excluded that additional mechanisms, such as abnormal dendritic plasticity, may contribute to the lack of anxiety observed in neuropsin 2/2 mice, particularly after long-lasting stress 24 .
To examine whether the effect of neuropsin was acute and not associated with the lack of the protease during development we bilaterally injected neuropsin into the amygdalae of neuropsin 2/2 mice ( Supplementary Fig. 18 ). The neuropsin injection restored stressinduced anxiety in these animals ( Fig. 4j ; P , 0.001). The development of anxiety was hindered by blocking EphB2 in the amygdala of wildtype mice ( Fig. 4k ; P , 0.001), consistent with neuropsin interacting with EphB2 to facilitate stress-induced behavioural changes. Similarly, stress-induced anxiety was blocked by silencing Fkbp5 gene expression in this brain region ( Fig. 4l and Supplementary Fig. 19 ), consistent with a downstream role of Fkbp5 in the neuropsin pathway.
Our studies favour a model where, after stress, both corticosteroneinduced and neuropsin-mediated components converge to modulate Fkbp5 gene expression and trigger anxiety ( Supplementary Fig. 20) . Neuropsin cleaves the extracellular portion of EphB2 and facilitates the dynamic interaction of EphB2 with the NR1 subunit of the NMDA receptor. The resulting enhancement of the NMDA current causes an upregulation of Fkbp5 and promotes the development of anxiety. This novel pathway, highlighting the ability of Eph and NMDA receptors to respond to activity-dependent signals from the extracellular milieu, opens new possibilities for the treatment of stress-associated disorders, including various forms of anxiety disorders.
METHODS SUMMARY
Restraint stress was performed by placing the mice in wire mesh restrainers while control mice were left undisturbed. Anxiety was measured using the elevated-plus maze by counting the number of entries to closed or open arms during 5 min. Intra-amygdala injections were performed through bilaterally implanted cannulae and were followed by restraint stress in plexiglass tubes. The Fkbp5 gene was silenced by intra-amygdala injection of lentiviral short hairpin RNA construct followed by behavioural assessment two weeks later. LTP was recorded from the lateral-basal pathway and whole-cell recordings made from basal amygdala neurons. Data were analysed by Student's t-test or ANOVA followed by Tukey's posttest. P values of less than 0.05 were considered significant.
METHODS
Mice. Experiments were performed on three-month-old wild-type (C57BL/6J) or neuropsin 2/2 mice backcrossed to C57BL/6J for 12 generations. To generate neuropsin 2/2 mice, exons 1-3 of the neuropsin gene, including the protease active site, were replaced by a neomycin resistance cassette 25 . A lack of full-length neuropsin transcript and proteolytic activity in the brain of these mice was confirmed by RT-PCR and amidolytic assay 25 , respectively. Neuropsin 2/2 mice were genotyped as described 13 . Mice were housed three to five per cage in a colony room with a 12 h light/dark cycle (lights on at 07:00) with ad libitum access to commercial chow and tap water. The experiments were approved by the UK Home Office and the University of Leicester Ethical Committee. Restraint stress. C57BL/6J and neuropsin 2/2 mice were kept undisturbed for at least one week in their home cages and restraint stress was performed during the light period of the circadian cycle as described 3 . Control animals were left undisturbed, and stressed animals were subjected to a single 5 min, 15 min or 6 h restraint stress in a separate room. The mice were placed in their home cages in wire mesh restrainers secured at the head and tail ends with clips. Primers. The primers for Ephb2 (forward 59-CTTCCTCATCGCTGTGGTC and reverse 59-ATGTGTCCGCTGGTGTAGTG) and Fkbp5 (forward 59-ATTTGAT TGCCGAGATGTG and reverse 59-TCTTCACCAGGGCTTTGTC) were bought from Invitrogen. To quantify gene expression the target genes were compared against the actin gene as previously described 26 . RNA extraction. Control and stressed mice were anaesthetized (intraperitoneal sodium pentobarbital 50 mg kg 21 ) and perfused transcardially (ice-cold PBS). Amygdalae were dissected from a coronal slice 20.58 to 22.3 mm relative to Bregma and stored in 'RNA later' (QIAgen) at 4 uC. Alternatively, RNA was extracted from primary amygdala neuronal cultures using QIAzol lysis reagent (QIAgen) and Mini Spin Columns according to the manufacturers' instructions (RNeasy Lipid tissue mini kit, QIAgen). Two micrograms of RNA was converted to cDNA using Superscript III (Invitrogen) and oligo(dT) primers according to manufacturer's instructions. Western blotting, cell fractionation and immunoprecipitation. Mice were anaesthetized (intraperitoneal sodium pentobarbital 50 mg kg 21 ) and perfused transcardially (ice-cold PBS). The brains were removed and amygdalae dissected from a slice 20.58 to 22.3 mm relative to Bregma. Samples were homogenized in 0.1 M Tris, 0.1% Triton X-100, pH 7.4, containing phosphatase inhibitors (10 mM NaF, 1 mM Na orthovanadate) and protease inhibitors (Complete, Roche). Protein concentration was adjusted (Bradford method; Pierce). For Fkbp51 levels samples were homogenized in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, 10 mM NaF, 1 mM Na orthovanadate, complete Roche protease inhibitors, pH 8.0). Reduced (DTT) and denatured (100 uC for 5 min) samples (40 mg per lane) were subjected to SDS-PAGE electrophoresis and transferred onto nitrocellulose membrane, blocked (5% skim milk for 1 h at room temperature (25 uC)) and washed with TBS-T (3 3 5 min). The membranes were probed with the following primary antibodies overnight at 4 uC: goat anti-NCAM L1 (SantaCruz Biotechnology; 1:300), goat anti-EphB2, anti-EphB6 and anti-ephrinB2 (R&D; 1:500, 1:500 and 1:300, respectively), mouse anti-EphA4 (Zymed; 1:1,000), rabbit anti-pan-cadherin (Abcam; 1:2,000), rabbit anti-p75NGF (Chemicon, 1:1,000), rabbit anti-NR1 (Upstate, 1:250), rabbit antineuropsin (H. C. Castro), rabbit anti-Fkbp51 (Abcam; 1:250). The membranes were then washed in TBS-T (3 3 10 min) and incubated with a relevant HRP-conjugated secondary antibody as appropriate (Vector Labs, 1:1,000, 1 h, room temperature). The signal was developed, after washing with TBS-T (6 3 10 min), using a Western Blot Luminol Reagent (Santa Cruz). To normalize the results the membranes were stripped, blocked, washed as above and re-blotted using mouse anti-b-actin antibody (Sigma, 1:2,500, 1 h, room temperature). The membranes were then prepared and developed as above. To quantify the results the band intensities were measured using Scion Image software and normalized to the actin bands.
When indicated, cellular fractions of the amygdala samples were separated using a cellular protein fractionation kit (PerkinElmer) as per the manufacturer's protocol, and analysed by western blotting.
For immunoprecipitation, amygdala samples were homogenized as previously described 27 , pre-cleared using goat IgG (Sigma, 1 mg) before incubation with goat anti-EphB2 antibody (R&D, 2 mg) for 1 h (4 uC). The samples were then incubated with protein G-sepharose beads overnight before being washed with PBS and analysed by western blotting.
Cell culture. SH-SY5Y cells at 80-90% confluence were washed with PBS three times before incubation with PBS, PBS and neuropsin (50 nM; R&D) or PBS and tissue plasminogen activator (tPA) (Alteplase, Genentech; 1 mg ml 21 ) with or without human plasminogen for 15 min, after which the dishes were placed on ice and protease inhibitors (Complete, Roche) were added. The cells were collected and homogenized in Tris 50 mM pH 7.5, NaCl 150 mM, EDTA 5 mM, EGTA 5 mM, Triton-100 1%, NP40 0.5%. The resulting protein sample was analysed by western blotting as described above.
SH-SY5Y and HEK293 cells were transfected with mouse EphB2-GFP and incubated with PBS or PBS 1 neuropsin (300 nM) for 15 or 45 min. The samples were then treated as above for analysis.
For imaging, SH-SY5Y cells were transfected with GFP, mouse EphB2-GFP or EphA4-GFP (gift from A. Kania) and loaded with the cell tracker (Invitrogen). Images were taken with Zeiss LSM5 Exciter before and after 15 min incubation with neuropsin (50 nM, R&D), converted to greyscale and the intensity of the fluorescent signal was analysed using Scion Image.
Primary neuronal cultures were prepared from P1 C57BL/6J wild-type mice. The amygdalae were dissected and placed into a Petri dish (9.1 mM glucose, 25 mM HEPES, 5 mM KCl and 120 mM NaCl). Tissue was chopped and incubated in 10 ml of buffer containing 5 mg of protease (Type XIV; Sigma) and 5 mg of thermolysin (Type X; Sigma) at room temperature for 30-45 min. The digestion solution was replaced with 3 ml of HBSS (Gibco) plus 40 mg ml 21 DNase. The mixture was titurated, centrifuged and resuspended in the plating medium (Neurobasal A medium, 10% fetal bovine serum, 2 mM Glutamax and 2% B-27 supplement, 100 mg ml 21 streptomycin, 100 U ml 21 penicillin (Invitrogen)), centrifuged and resuspended again. 20-30 ml droplets containing cells were added to the centre of poly-D-lysine (Sigma) coated coverslips and the plating medium was added one hour later. 5 mM cytosine B-D-arabinofuranoside (Ara-C; Sigma) was added to prevent proliferation of glial cells. Neurons were maintained in serum-free Neurobasal A medium at 37 uC in a humidified atmosphere of 5% CO 2 /95% air. Half of the medium was replaced every 3-4 days. Cells were maintained for 11-16 days in vitro and then treated with either vehicle, corticosterone (10 nM), neuropsin (50 nM) or NMDA (100 mM, Sigma) 1 glycine (10 mM, Sigma). To block EphB2, neurons were treated with anti-EphB2 antibody (2 mg ml 21 ; R&D) 10 min before the experiment. Electrophysiology. For field recordings coronal slices of the amygdala (400 mm) were obtained from 8-12 weeks-old neuropsin 2/2 and wild-type mice. The animals were anaesthetized with ketamine/xylazine (2:1 ratio; 2.4 ml g 21 i.p.). Slices were prepared using a vibrating microtome (Campden Instruments; MA752) in ice-cold, low sodium ACSF (sucrose 249 mM, KCl 2.5 mM, NaH 2 PO 4 1.25 mM, D-glucose 10 mM, NaHCO 3 26 mM, CaCl 2 0.1 mM, MgSO 4 2.9 mM, ascorbic acid 0.5 mM, bubbled with 95% O 2 /5% CO 2 mixture, pH 7.3). Slices were placed in a holding chamber for 30 min at 35 uC and then for at least 2.5 h (30 min for whole-cell recordings) at room temperature (25 uC) in ACSF (NaCl 124 mM, KCl 5 mM, NaH 2 PO 4 1.25 mM, D-glucose 10 mM, NaHCO 3 26 mM, CaCl 2 2.4 mM, MgSO 4 1.3 mM). All the experiments were performed at room temperature.
Extracellular recording were made with a bipolar tungsten electrode (WPI). For recordings, glass microelectrodes (1-2 MV) filled with ACSF were used. To record field potentials in the lateral-basal amygdala pathway the stimulating electrode was positioned in the lateral amygdaloid nucleus close to the external capsule and the recording electrode in the basal nucleus 28 . The stimulus intensity was adjusted to evoke a field potential (FP) of 60-70% (0.2 ms pulse duration) of the maximal amplitude. The amygdala was stimulated every 30 s in order to record a stable baseline for at least 15 min. Several responses were averaged and a template was created. Only the responses matching the template were analysed. E-LTP was evoked by a single tetanic stimulation (100 Hz, 1 s). L-LTP were elicited by two tetanic stimulations (100 Hz, 1 s, 10 s interval) repeated 4 times in 3 min intervals with the same intensity and pulse duration as the test stimuli as described 29 . The recordings were amplified (Multiclamp 700b, Axon Instruments), filtered (10 kHz) and digitized at 50 kHz (Digidata 1440A, Axon Instruments). pClamp 10 (Axon Instruments) and Origin 7 (Microcal) software were routinely used during data acquisition and analysis.
For whole-cell recordings, coronal slices (300 mm) were obtained from 3-4week-old mice. The animals were anaesthetized with hypnorm/midazolam (1:1; 8 ml g 21 body weight, intraperitoneally). Recordings were made from somata of principal neurons of the basal nucleus of the amygdala. Principal neurons and interneurons were distinguished by their morphological and electrophysiological properties 30 . After whole-cell configuration the series resistance was regularly monitored and a maximum of 10-15 MV tolerated. AMPA and NMDA currents were recorded by clamping the membrane potential of the cell at 270 mV and 140 mV respectively (average of 5 traces each). The slice was subsequently perfused with AP-5 in order to isolate the NMDA component at 140 mV (subtraction of traces before and after perfusion with AP-5). The NMDA/AMPA ratio was RESEARCH LETTER obtained by measuring the peak of the AMPA current at 270 mV in the presence of AP-5 and the peak of NMDA current at 140 mV. At the end of the experiments the currents were blocked by CNQX (30 mM in DMSO) and AP-5 (50 mM in DMSO). All drugs were bath applied (perfusion rate 1.5 ml min 21 ). The recording electrodes were borosilicate glass pipettes (2-4 MV). The pipettes were filled with the following solution: Cs-methyl sulphonate 130 mM, KCl 8 mM, EGTA 0.5 mM, HEPES 10 mM, glucose 5 mM, QX314 5 mM. ACSF composition: NaCl 124 mM, KCl 5 mM, NaH 2 PO 4 1.25 mM, D-glucose 10 mM, NaHCO 3 26 mM, CaCl 2 2 mM, MgSO 4 1 mM. All the experiments were performed at 25 uC. Data were recorded with a Multiclamp 700B amplifier, filtered at 10 kHz and digitized at 50 kHz (Digidata 1440A, Axon instruments). pClamp 10 (Axon Instruments) and Origin 7 (Microcal) software was routinely used during data acquisition and analysis. Analysis of the Fkbp5 promoter. The identification of over-represented transcription factor binding sites (TFBSs) in the promoter region of Fkbp5 was performed using the cREMaG database (http://cremag.org). The promoter region of Fkbp5 was defined as an evolutionarily conserved (on the basis of the alignment of mouse and human genes) sequence between 10,000 bp upstream and 5,000 bp downstream of the transcription start site (TSS). The parameters of 65% conservation threshold and maximum number of top 10,000 conserved TFBSs in coding and non-coding regions were used. The obtained results were compared to conserved promoter background. Over-representation was measured as the number of identified TFBSs compared to putative number obtained by chance (P , 0.01). Microarray study. Amygdalae were isolated from wild-type (n 5 15) and neuropsin 2/2 (n 5 15) mice using a dissecting microscope in ice-cold ACSF (glucose 25 mM, NaCl 115 mM, NaH 2 PO 4 ?H 2 O 1.2 mM, KCl 3.3 mM, CaCl 2 , 2 mM,
